IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

TRV GP II, LLC

Q1 2018 Holdings

Filed 2018-04-19 | 5 holdings | $533.6K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Jounce Therapeutics, Inc.(JNCEEUR)COM481116101$228.6K10,230,34942.8%
Blueprint Medicines Corporation(2L9)COM09627Y109$225.0K2,453,75342.2%
Myokardia, Inc.COM62857M105$43.2K885,1048.1%
Allena Pharmaceuticals, Inc.(ALNAEUR)COM018119107$30.8K2,790,9645.8%
Sage Therapeutics, Inc.(SG7)COM78667J108$6.0K37,3621.1%